title: Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
abstract: Waldenström's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses-including array-based comparative genomic hybridization and massively parallel genome sequencing-have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.
authors.affiliation: Department of Hematology-Oncology, Mayo Clinic, 13400 East Shea Boulevard, Collaborative Research Building, Room 3-028, Scottsdale, AZ, 85259-5494, USA, mongeurrea.jorge@mayo.edu.
authors.forename: Jorge
authors.initials: J
authors.lastname: Monge
authors.forename: Esteban
authors.initials: E
authors.lastname: Braggio
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Ansell
mesh_terms: D020732:Cytogenetic Analysis / Q000379:methods; D044127:Epigenesis, Genetic / Q000235:genetics; D016678:Genome; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000379:methods; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy / Q000235:genetics*
chemical_list: D035683:MicroRNAs
references.citation: Blood. 2012 Oct 18;120(16):3214-21
references.pmid: 22896002
references.citation: Am J Hematol. 2012 May;87(5):503-10
references.pmid: 22508368
references.citation: Blood. 2011 Mar 10;117(10):2918-23
references.pmid: 21220746
references.citation: Eur J Haematol. 2007 Sep;79(3):244-7
references.pmid: 17655703
references.citation: Cancer Res. 2009 Apr 15;69(8):3579-88
references.pmid: 19351844
references.citation: Clin Lymphoma Myeloma. 2009 Mar;9(1):39-42
references.pmid: 19362969
references.citation: Blood. 2009 Apr 30;113(18):4163-70
references.pmid: 19196866
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9
references.pmid: 16166262
references.citation: Blood. 2013 Mar 14;121(11):2051-8
references.pmid: 23321251
references.citation: Ann Oncol. 2012 Feb;23(2):411-5
references.pmid: 21525403
references.citation: Cancer Genet Cytogenet. 2006 Sep;169(2):150-3
references.pmid: 16938573
references.citation: Cell. 1997 Feb 7;88(3):323-31
references.pmid: 9039259
references.citation: Semin Oncol. 2003 Apr;30(2):110-5
references.pmid: 12720118
references.citation: Cancer Cell. 2007 Aug;12(2):131-44
references.pmid: 17692805
references.citation: Lancet Oncol. 2003 Nov;4(11):679-85
references.pmid: 14602248
references.citation: Ann Oncol. 2006 Mar;17(3):488-94
references.pmid: 16357024
references.citation: N Engl J Med. 2000 Dec 28;343(26):1910-6
references.pmid: 11136261
references.citation: Blood. 2010 Sep 2;116(9):1506-14
references.pmid: 20519629
references.citation: Haematologica. 2008 May;93(5):670-9
references.pmid: 18367492
references.citation: Blood. 2009 Apr 30;113(18):4391-402
references.pmid: 19074725
references.citation: Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):184-6
references.pmid: 23490989
references.citation: Semin Oncol. 2003 Apr;30(2):169-71
references.pmid: 12720130
references.citation: J Clin Oncol. 1999 Dec;17(12):3835-49
references.pmid: 10577857
references.citation: Am J Clin Pathol. 2001 Sep;116(3):420-8
references.pmid: 11554171
references.citation: Blood. 2010 Jun 3;115(22):4464-71
references.pmid: 20308603
references.citation: Ann Oncol. 2012 Feb;23(2):542-3
references.pmid: 22100692
references.citation: Br J Haematol. 2007 Jan;136(1):80-6
references.pmid: 17222197
references.citation: Yonsei Med J. 2011 May;52(3):379-92
references.pmid: 21488180
references.citation: Am J Hum Genet. 2006 Oct;79(4):695-701
references.pmid: 16960805
references.citation: Blood. 2009 May 14;113(20):4918-21
references.pmid: 19258598
references.citation: J Hematol Oncol. 2010 Oct 07;3:38
references.pmid: 20929526
references.citation: Semin Oncol. 2003 Apr;30(2):187-95
references.pmid: 12720134
references.citation: Blood. 2000 Aug 1;96(3):852-8
references.pmid: 10910896
references.citation: Blood. 2006 Oct 15;108(8):2755-63
references.pmid: 16804116
references.citation: Br J Haematol. 2009 Apr;145(1):59-63
references.pmid: 19220283
references.citation: Leukemia. 2004 Jun;18(6):1160-2
references.pmid: 15103388
references.citation: Br J Haematol. 2011 Jul;154(2):223-8
references.pmid: 21564078
references.citation: Leukemia. 2007 Mar;21(3):541-9
references.pmid: 17252022
references.citation: Haematologica. 2013 Apr;98(4):649-54
references.pmid: 23065509
references.citation: Mod Pathol. 2012 May;25(5):651-60
references.pmid: 22301699
references.citation: Br J Haematol. 2001 Dec;115(3):575-82
references.pmid: 11736938
references.citation: Nature. 2011 Feb 3;470(7332):115-9
references.pmid: 21179087
references.citation: N Engl J Med. 2012 Aug 30;367(9):826-33
references.pmid: 22931316
references.citation: Nature. 2009 Jun 4;459(7247):717-21
references.pmid: 19412164
references.citation: Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):211-3
references.pmid: 23523273
references.citation: Leukemia. 2004 Aug;18(8):1433-5
references.pmid: 15201850
references.citation: Blood. 2002 Oct 15;100(8):2996-3001
references.pmid: 12351413
references.citation: Blood. 2013 Mar 28;121(13):2522-8
references.pmid: 23355535
references.citation: Mayo Clin Proc. 2010 Sep;85(9):824-33
references.pmid: 20702770
references.citation: J Natl Compr Canc Netw. 2012 Oct 1;10(10):1211-9
references.pmid: 23054875
references.citation: Haematologica. 2008 May;93(5):793-4
references.pmid: 18450739
references.citation: N Engl J Med. 2002 Feb 21;346(8):564-9
references.pmid: 11856795
references.citation: Am J Clin Pathol. 2001 Oct;116(4):543-9
references.pmid: 11601139
references.citation: Expert Rev Hematol. 2012 Apr;5(2):187-99
references.pmid: 22475287
references.citation: Br J Haematol. 2006 Apr;133(2):158-64
references.pmid: 16611306
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
references.pmid: 12434020
references.citation: Bone Marrow Transplant. 2012 Mar;47(3):330-6
references.pmid: 21572463
references.citation: Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):433-7
references.pmid: 23084402
references.citation: Clin Cancer Res. 2005 Mar 1;11(5):1786-90
references.pmid: 15756000
references.citation: Mediators Inflamm. 2010;2010:781235
references.pmid: 20981241
references.citation: Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):202-4
references.pmid: 23473949
references.citation: Leuk Lymphoma. 2013 Mar;54(3):464-71
references.pmid: 22860921
references.citation: Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):112-4
references.pmid: 21454207
references.citation: Leukemia. 2006 Sep;20(9):1634-6
references.pmid: 16838026
references.citation: Oncologist. 2000;5(1):63-7
references.pmid: 10706651
references.citation: Semin Oncol. 2003 Apr;30(2):226-30
references.pmid: 12720141
references.citation: Semin Oncol. 2003 Apr;30(2):146-52
references.pmid: 12720125
references.citation: Cancer Cell. 2007 Aug;12(2):115-30
references.pmid: 17692804
references.citation: Cancer. 2012 Aug 1;118(15):3793-800
references.pmid: 22139816
references.citation: Cancer Genet Cytogenet. 1998 Feb;101(1):7-11
references.pmid: 9460493
references.citation: Blood Cancer J. 2011 Jun;1(6):e24
references.pmid: 22829168
references.citation: Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):205-7
references.pmid: 23474146
references.citation: Blood. 2012 Oct 18;120(16):3163-4
references.pmid: 23086619